Stock Market News

Biogen advances Alzheimer's drug to late-stage trial despite disappointing data

wcc wcc
May 14, 2026 - 17:26
0 1
Biogen advances Alzheimer's drug to late-stage trial despite disappointing data
Biogen said signals suggest the treatment decreases levels of tau and slows cognitive decline, particularly at the lowest dose.

Previous Article

Crypto industry scores win as Clarity Act regulation bill clears Senate hurdle

Next Article

Cerebras almost doubles in Nasdaq debut, topping $100 billion market cap afte...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0
wcc
wcc

Related Posts

These 4 Earnings Reports Expose the Market’s Growing Economic Divide

These 4 Earnings Reports Expose the Market’s Growing...

wcc
Jul 28, 2026
0
1
Warren Buffett Built a $397 Billion War Chest. Berkshire Can Buy Almost Every S&P 500 Company

Warren Buffett Built a $397 Billion War Chest. Berks...

wcc
Jul 28, 2026
0
1
Mortgage and refinance rates today, Monday, July 27, 2026: Purchase rates higher than refinance rates

Mortgage and refinance rates today, Monday, July 27,...

wcc
Jul 28, 2026
0
1
Standard Chartered: Oil Markets Must Now Price Two Middle East Chokepoints

Standard Chartered: Oil Markets Must Now Price Two M...

wcc
Jul 28, 2026
0
1

U.S. and Korean tech stocks are now tightly linked —...

wcc
Jul 28, 2026
0
1

Indonesian stocks stage massive turnaround, hitting ...

wcc
Jul 28, 2026
0
0

Comments (0)

User